2026 Q2 Shareholder Letter

July 30, 2026 Dear Fellow Shareholders: A year ago, we wrote to you about the travails of our UnitedHealth investment. The stock lost over half its value in about a month, an extraordinary change for…


Read More

2026 Q1 Shareholder Letter

April 21, 2026 Dear Fellow Shareholders: The market volatility over the last quarter and past year hasn’t done our portfolio any favors. Given that we currently own only 18 stocks—versus 500 for the…


Read More

2025 Q4 Shareholder Letter

February 12, 2026 Dear Fellow Shareholders: While the market seems to alternate on a day-to-day basis between euphoria and apprehension about a bubble in artificial intelligence, we don’t believe the…


Read More

2025 Distribution Information

The Bretton Fund made a long-term capital-gain distribution to shareholders on December 17, 2025, of $1.228486 per share, amounting to about 1.5% of the fund’s NAV. There were no other distributions…


Read More

2025 Q3 Shareholder Letter

October 22, 2025 Dear Fellow Shareholders: The main event for the fund this quarter was the favorable antitrust ruling for Alphabet’s Google. A federal judge had earlier this year deemed Google a…


Read More

2025 Q2 Shareholder Letter

July 25, 2025 Dear Fellow Shareholders: A lot can change in a quarter. The president backed down from the most draconian version of his tariff threats, and the market staged a relief rally, which…


Read More

2025 Q1 Shareholder Letter

April 23, 2025 Dear Fellow Shareholders: We don't talk much about politics for a good reason: people tend to overstate its impact on the stock market. The central tendencies of the economy span…


Read More

2024 Q4 Shareholder Letter

2024 Annual Shareholder Report (pdf) February 6, 2025 Dear Fellow Shareholders: With the market stacking two back-to-back years of ~25% returns—and 15 years of mid-teens returns—we thought this would…


Read More

2024 Distribution Information

The Bretton Fund made a long-term capital-gain distribution to shareholders on December 19, 2024, of $0.798764 per share, amounting to 1% of the fund’s NAV. There were no other distributions for the…


Read More

2024 Q3 Shareholder Letter

October 23, 2024 Dear Fellow Shareholders: Both the fund and the market reached all-time highs again this quarter, along with many of our holdings. While it’s extremely unlikely the next 12 months…


Read More

Need to reach us? Call or email us.

The fund's investment objectives, risks, charges and expenses must be considered carefully before investing. The prospectus contains this and other important information about the investment company, and it may be obtained here or by calling 800.231.2901. Read it carefully before investing. An investment in the fund is subject to investment risks, including the possible loss of the principal amount invested. There can be no assurance that the fund will be successful in meeting its objectives. The fund invests in common stocks which subjects investors to market risk. The fund invests in small and micro-cap companies, which involve additional risks such as limited liquidity and greater volatility. The fund invests in undervalued securities. Undervalued securities are, by definition, out of favor with investors, and there is no way to predict when, if ever, the securities may return to favor. The fund invests in foreign securities which involve greater volatility and political, economic and currency risks and differences in accounting methods. Investments in debt securities typically decrease in value when interest rates rise. This risk is usually greater for longer-term debt securities. More information about these risks and other risks can be found in the fund’s prospectus. The fund is a nondiversified fund and therefore may be subject to greater volatility than a more diversified investment. Distributed by Arbor Court Capital, LLC - Member FINRA / SIPC

Privacy Preference Center